HMD Labs appoints Josh DeFonzo to join Board of Directors
Company continues growth and expansion, launching development of next generation med devices
September 21, 2021 (SAN FRANCISCO, CA) — San Francisco-based HMD Labs, a provider of next-generation cloud data platforms that accelerates the digital transformation of medical devices across the healthcare industry, announced today that Josh DeFonzo, CEO and Director of Lux Health Tech Acquisition Corp., will join HMD Labs co-founders Kevin Derr and Brian Greene on the Board of Directors. HMD Labs partners with medical device startups and provides a comprehensive and cost-effective data architecture platform, that can be tailored to specific needs. Medical devices approved by the FDA have increased by 28 percent between 2019 and 2020. This growth is expected to continue with the global market for intelligent medical devices projected to reach $612.7 billion by the end of 2021.
At the helm of Lux Health Tech Acquisition Corp, DeFonzo leads the $345 million Special Purpose Acquisition Corporation, focusing on generational companies innovating at the intersection of healthcare and technology.
“Josh DeFonzo’s extensive experience developing new technology and markets, coupled with his passionate energy for early stage ventures and entrepreneurial opportunities, fits perfectly with the HMD Labs culture,” said Kevin Derr, Chief Executive Officer. “His strategic and technology development expertise will play an integral role in our future operations and strategy.”
In addition to his work at Lux Health, DeFonzo also serves as co-founder and CEO of Menadeara, Inc, an early stage company developing a platform that integrates real time imaging, robotics and AI to enable physicians to more consistently perform point-of-care intervention.
HMD Labs next-generation cloud data platform, NeuronSphere™, is a complete ecosystem of components, tools and SaaS services specifically designed for intelligent medical device startups. NeuronSphere™ provides unique turnkey access to data capabilities required by medical device companies, enabling reliable, scalable, compliant data pipelines that are fully customized to each organization’s specific use-cases. Capabilities include: SaaS-based data and analytics infrastructure orchestration, integrated compliance and security, intuitive workspaces and visualizations for online and offline use, as well as optimization for all roles and requirements across the intelligent medical device startup lifecycle from R&D through market success.
Visit our NeuronSphere website for more information.
